BIOMAT Database Logo BIOMAT Database Logo

Bioavailability of prolonged action fenfluramine. 1975

R Tozer, and D B Campbell, and P G Leivers, and J A Edwards

UI MeSH Term Description Entries
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005260 Female Females
D005277 Fenfluramine A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release. Fintepla,Fenfluramine Hydrochloride,Fenfluramine Hydrochloride, (+-)-Isomer,Fenfluramine Hydrochloride, R-Isomer,Fenfluramine, (+-)-Isomer,Fenfluramine, R-Isomer,Isomeride,Pondimin,Fenfluramine Hydrochloride, R Isomer,Fenfluramine, R Isomer,Hydrochloride, Fenfluramine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

R Tozer, and D B Campbell, and P G Leivers, and J A Edwards
Prolonged action fenfluramine in general practice.
January 1975, The British journal of clinical practice,
R Tozer, and D B Campbell, and P G Leivers, and J A Edwards
Prolonged action fenfluramine capsules versus fenfluramine tablets in general practice.
January 1975, The British journal of clinical practice,
R Tozer, and D B Campbell, and P G Leivers, and J A Edwards
Prolonged-action fenfluramine in non-diabetic patients with refractory obesity.
January 1975, Postgraduate medical journal,
R Tozer, and D B Campbell, and P G Leivers, and J A Edwards
Action of fenfluramine.
January 1973, Lancet (London, England),
R Tozer, and D B Campbell, and P G Leivers, and J A Edwards
Metabolic effects and anti-obesity action of fenfluramine in prolonged-acting form.
January 1977, Current medical research and opinion,
R Tozer, and D B Campbell, and P G Leivers, and J A Edwards
Central D-fenfluramine action.
October 1975, Polish journal of pharmacology and pharmacy,
R Tozer, and D B Campbell, and P G Leivers, and J A Edwards
A comparison of the efficacy and acceptability of fenfluramine tablets (BP) and prolonged action capsules.
January 1975, Postgraduate medical journal,
R Tozer, and D B Campbell, and P G Leivers, and J A Edwards
Anti-obesity action of fenfluramine.
May 1972, The Practitioner,
R Tozer, and D B Campbell, and P G Leivers, and J A Edwards
The mechanism of action of fenfluramine.
January 1975, Postgraduate medical journal,
R Tozer, and D B Campbell, and P G Leivers, and J A Edwards
[Side effects associated with prolonged use of fenfluramine].
March 1973, La Vie medicale au Canada francais,
Copied contents to your clipboard!